Insider Trading History of Walker Neal

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Walker Neal since 2014. This trader's CIK number is 1604457. At the time of last reporting, Walker Neal was the CEO of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS). Also see all insider trading activities at Aclaris Therapeutics, Inc..

Note that in the past Walker Neal also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Walker Neal

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ACRS 0 $0 0 $0 67,017 $0
2024 ACRS 0 $0 0 $0 247,588 $211,990
2023 ACRS 0 $0 129,240 $1,855,167 156,679 $0
2022 ACRS 0 $0 126,303 $1,956,772 143,479 $0
2021 ACRS 0 $0 63,260 $1,533,790 198,218 $0
2020 ACRS 0 $0 0 $0 318,654 $0
2019 ACRS 0 $0 0 $0 16,758 $0
2018 ACRS 10,000 $167,500 0 $0 18,091 $0
2017 ACRS 0 $0 0 $0 5,958 $0
2016 ACRS 0 $0 0 $0 2,925 $0

Yearly summary of insider trading at Aldeyra Therapeutics, Inc. (ALDX) by Walker Neal

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ALDX 0 $0 0 $0 9,604 $5,301
2014 ALDX 6,250 $50,000 0 $0 0 $0


Insider trading activities at 2 companies by Walker Neal:

1. Aclaris Therapeutics, Inc. (ACRS)

2. Aldeyra Therapeutics, Inc. (ALDX)

Table 1. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Walker Neal

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-01 ACRS Option Ex 9,467 .00 0
2025-04-01 ACRS Option Ex 9,467 .00 0
2025-02-01 ACRS Option Ex 9,467 .00 0
2025-01-01 ACRS Option Ex 9,467 .00 0
2025-01-02 ACRS Option Ex 29,149 .00 0
2024-12-04 ACRS Option Ex 118,840 1.52 180,636
2024-11-01 ACRS Option Ex 9,467 .00 0
2024-10-01 ACRS Option Ex 9,467 .00 0
2024-09-01 ACRS Option Ex 9,466 .00 0
2024-08-09 ACRS Option Ex 43,548 .72 31,354
2024-08-01 ACRS Option Ex 9,467 .00 0
2024-07-01 ACRS Option Ex 9,467 .00 0
2024-06-01 ACRS Option Ex 9,466 .00 0
2024-05-01 ACRS Option Ex 9,467 .00 0
2024-04-01 ACRS Option Ex 9,467 .00 0
2024-03-01 ACRS Option Ex 9,466 .00 0
2023-03-01 ACRS Option Ex 138,425 .00 0
2023-03-02 ACRS Option Ex 18,254 .00 0
2023-03-02 ACRS Sale 29,000 12.37 358,585
2023-03-03 ACRS Sale 30,240 12.63 382,082
2023-02-02 ACRS Sale 5,000 16.14 80,675
2023-02-01 ACRS Sale 25,000 16.75 418,675
2023-01-03 ACRS Sale 25,000 15.67 391,800
2023-01-04 ACRS Sale 15,000 14.89 223,350
2022-04-25 ACRS Sale 20,000 15.18 303,660
2022-04-21 ACRS Sale 25,000 15.24 380,950
2022-04-22 ACRS Sale 25,000 15.04 376,100
2022-03-11 ACRS Sale 56,303 15.91 896,062
2022-03-01 ACRS Option Ex 114,425 .00 0
2022-03-02 ACRS Option Ex 18,254 .00 0
2022-02-01 ACRS Option Ex 10,800 .00 0
2021-06-02 ACRS Sale 33,260 21.91 728,560
2021-06-01 ACRS Option Ex 73,015 .00 0
2021-04-22 ACRS Sale 30,000 26.84 805,230
2021-03-02 ACRS Option Ex 18,253 .00 0
2021-03-01 ACRS Option Ex 96,150 .00 0
2021-02-01 ACRS Option Ex 10,800 .00 0
2020-12-15 ACRS Option Ex 3,034 .00 0
2020-09-01 ACRS Option Ex 83,092 .00 0
2020-06-01 ACRS Option Ex 73,014 .00 0
2020-03-02 ACRS Option Ex 148,714 .00 0
2020-02-03 ACRS Option Ex 10,800 .00 0
2019-12-18 ACRS Option Ex 2,925 .00 0
2019-12-16 ACRS Option Ex 3,033 .00 0
2019-02-01 ACRS Option Ex 10,800 .00 0
2018-12-18 ACRS Option Ex 2,925 .00 0
2018-12-15 ACRS Option Ex 3,033 .00 0
2018-05-07 ACRS Option Ex 12,133 .00 0
2018-04-05 ACRS Buy 10,000 16.75 167,500
2017-12-18 ACRS Option Ex 2,925 .00 0
2017-12-15 ACRS Option Ex 3,033 .00 0
2016-12-18 ACRS Option Ex 2,925 .00 0

Table 2. Insider trading of Aldeyra Therapeutics, Inc. (ALDX) by Walker Neal

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-08-22 ALDX Option Ex 9,604 .55 5,301
2014-05-07 ALDX Buy 6,250 8.00 50,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Walker Neal (CEO of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.